l carnitine and metabolism Carnitine: Genetic Variants Affecting Mitochondrial Energy Health JCI - l-Carnitine in omnivorous
Description
The compound was developed by the Canadian biotech Theratechnologies and received FDA approval on 10 November 2010 for the reduction of excess visceral adipose tissue (VAT) in HIV-infected patients with lipodystrophy
The results suggest that NZB/W mice have increased expression of senescence markers such as FOXO4, rH2AX, and p16, and that senescent cells can be targeted in the kidney of patients with lupus
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Jain S
Orthopedics 28:573-579, 2005
